Close Menu

Xceed Molecular

Under the terms of the deal, Holliston, Mass.-based Digilab will sell Axela's Ziplex system for gene and protein expression analysis and dotLab mX system for real-time immunoassays.

Axela to date has focused on providing protein analysis tools and services, and the addition of Xceed's Ziplex System for gene expression analysis will support its ambitions to speed the validation and clinical application of DNA, RNA, and protein biomarkers.

The deal combines Axela's multiplex protein biomarker testing capabilities and Xceed's Ziplex System for gene expression analysis, with a focus on multiplex diagnostic assays.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.